JW Lifescience Statistics

Total Valuation

JW Lifescience has a market cap or net worth of KRW 174.67 billion. The enterprise value is 163.68 billion.

Market Cap	174.67B
Enterprise Value	163.68B

Important Dates

The next estimated earnings date is Wednesday, February 5, 2025.

Earnings Date	Feb 5, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

JW Lifescience has 15.48 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	15.48M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	1.11%
Float	8.56M

Valuation Ratios

The trailing PE ratio is 6.06.

PE Ratio	6.06
Forward PE	n/a
PS Ratio	0.79
PB Ratio	1.03
P/TBV Ratio	1.05
P/FCF Ratio	3.66
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.10, with an EV/FCF ratio of 3.43.

EV / Earnings	5.68
EV / Sales	0.74
EV / EBITDA	3.10
EV / EBIT	4.41
EV / FCF	3.43

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.26.

Current Ratio	2.09
Quick Ratio	1.61
Debt / Equity	0.26
Debt / EBITDA	0.89
Debt / FCF	0.94
Interest Coverage	15.77

Financial Efficiency

Return on equity (ROE) is 17.97% and return on invested capital (ROIC) is 10.21%.

Return on Equity (ROE)	17.97%
Return on Assets (ROA)	8.36%
Return on Capital (ROIC)	10.21%
Revenue Per Employee	735.28M
Profits Per Employee	95.74M
Employee Count	301
Asset Turnover	0.86
Inventory Turnover	7.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.55% in the last 52 weeks. The beta is 0.63, so JW Lifescience's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-14.55%
50-Day Moving Average	11,223.60
200-Day Moving Average	11,764.75
Relative Strength Index (RSI)	48.94
Average Volume (20 Days)	30,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, JW Lifescience had revenue of KRW 221.32 billion and earned 28.82 billion in profits. Earnings per share was 1,860.99.

Revenue	221.32B
Gross Profit	56.56B
Operating Income	34.25B
Pretax Income	34.97B
Net Income	28.82B
EBITDA	50.00B
EBIT	34.25B
Earnings Per Share (EPS)	1,860.99

Full Income Statement

Balance Sheet

The company has 55.72 billion in cash and 44.74 billion in debt, giving a net cash position of 10.98 billion or 709.24 per share.

Cash & Cash Equivalents	55.72B
Total Debt	44.74B
Net Cash	10.98B
Net Cash Per Share	709.24
Equity (Book Value)	170.20B
Book Value Per Share	10,991.78
Working Capital	64.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 56.15 billion and capital expenditures -8.39 billion, giving a free cash flow of 47.76 billion.

Operating Cash Flow	56.15B
Capital Expenditures	-8.39B
Free Cash Flow	47.76B
FCF Per Share	3,084.61

Full Cash Flow Statement

Margins

Gross margin is 25.56%, with operating and profit margins of 15.48% and 13.02%.

Gross Margin	25.56%
Operating Margin	15.48%
Pretax Margin	15.80%
Profit Margin	13.02%
EBITDA Margin	22.59%
EBIT Margin	15.48%
FCF Margin	21.58%

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 4.43%.

Dividend Per Share	500.00
Dividend Yield	4.43%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	26.87%
Buyback Yield	n/a
Shareholder Yield	4.43%
Earnings Yield	16.50%
FCF Yield	27.35%

Dividend Details

Stock Splits

The last stock split was on April 20, 2018. It was a forward split with a ratio of 2.

Last Split Date	Apr 20, 2018
Split Type	Forward
Split Ratio	2

Scores

JW Lifescience has an Altman Z-Score of 3.4.

Altman Z-Score	3.4
Piotroski F-Score	n/a